skip to main content

SGLT2 inhibitor euglycaemic ketoacidosis — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardEndocrine TherapeuticsSGLT2 inhibitor euglycaemic ketoacidosisGPhC CRA

A 55-year-old woman takes empagliflozin, metformin and ramipril. She presents with vomiting, abdominal pain and rapid breathing after a viral illness; her capillary glucose is 9.8mmol/L. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: DRefer urgently for possible euglycaemic diabetic ketoacidosis and advise withholding empagliflozin during acute illness.

SGLT2 inhibitors can cause diabetic ketoacidosis with only modest glucose elevation. Vomiting, abdominal pain and rapid breathing are red flags requiring urgent assessment. Sick-day advice includes withholding SGLT2 inhibitors during acute dehydrating illness and seeking medical advice.

Reference: MHRA Drug Safety Update; BNF